Editorial
doi: 10.1158/1078-0432.CCR-22-3087.
Liquid Biopsies for Cancer Genotyping: Coming of Age?
Affiliations
- PMID: 36757332
- DOI: 10.1158/1078-0432.CCR-22-3087
Item in Clipboard
Editorial
Liquid Biopsies for Cancer Genotyping: Coming of Age?
Clin Cancer Res.
.
Abstract
Precision oncology is predicated on optimal molecular profiling that is "fit for purpose" to identify therapeutic vulnerabilities. Liquid biopsies may compensate for inadequate genotyping, but remain less sensitive and specific compared with tissue biopsies. The liquid biopsy toolbox is poised to expand through novel assays and insights from longitudinal profiling. See related article by Sugimoto et al., p. 1506.
©2023 American Association for Cancer Research.
Comment in
-
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid).Clin Cancer Res. 2023 Apr 14;29(8):1506-1514. doi: 10.1158/1078-0432.CCR-22-1749. Clin Cancer Res. 2023. PMID: 36201167
Comment on
-
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid).Clin Cancer Res. 2023 Apr 14;29(8):1506-1514. doi: 10.1158/1078-0432.CCR-22-1749. Clin Cancer Res. 2023. PMID: 36201167
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
